Skip to content

Clinical trials

Completed Carcinoma, Hepatocellular trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Status: Completed Country / region: Hong Kong Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20052
20064
20073
20083
20095
20105
20113
20122
20138
20145
20154
20163
20173
20182
20195
20205
20211
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer8
Chinese University of Hong Kong8
Bristol-Myers Squibb7
Hoffmann-La Roche5
Novartis Pharmaceuticals5
The University of Hong Kong5
AstraZeneca4
Bio-Cancer Treatment International Limited4
Eli Lilly and Company3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular71
Liver Neoplasms22
Neoplasms8
Carcinoma4
Hepatitis B2
Liver Diseases2
Vaccinia2
Adenocarcinoma1
Adenoma, Islet Cell1
Biliary Tract Neoplasms1

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.